Form 4: 908 Devices Inc. Executive Michael S. Turner Reports Stock Option and Restricted Stock Unit Grants
SEC Form 4
Michael S. Turner, Chief Legal & Admin Officer of 908 Devices Inc., reports the acquisition of stock options and restricted stock units.
Summary
- On March 1, 2024, Michael S. Turner, Chief Legal & Admin Officer of 908 Devices Inc., reported the acquisition of stock options and restricted stock units.
- Turner acquired options to buy 59,201 shares of common stock at an exercise price of $7.35.
- These options vest over time, starting with 25% on February 1, 2025, and the remainder in monthly installments over the following 36 months.
- Turner also acquired 43,334 restricted stock units (RSUs), each representing a contingent right to receive one share of common stock.
- These RSUs vest with 25% on February 1, 2025, and the remaining 75% vesting in three equal annual installments thereafter.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. The sentiment is neutral to positive as it incentivizes long-term performance.
Positives
- The grant of stock options and RSUs aligns the executive's interests with those of the shareholders.
- The vesting schedules encourage long-term commitment from the executive.
Future Outlook
The vesting schedules for both the stock options and RSUs suggest a focus on long-term performance and retention of the executive.
Industry Context
Stock option and RSU grants are common compensation practices for executives in publicly traded companies, aligning their interests with shareholder value and incentivizing long-term growth.
Comparison to Industry Standards
- Stock option and RSU grants are standard practice in the tech and biotech industries for executive compensation.
- Vesting schedules are typically structured to incentivize long-term performance, often over a 3-4 year period, which aligns with the vesting terms described in the document.
- Companies like Thermo Fisher Scientific, Agilent Technologies, and Danaher Corporation also utilize similar equity-based compensation plans for their executives.
Stakeholder Impact
- Shareholders may view the grants positively as they align executive interests with company performance.
- Employees may see this as a positive sign of investment in leadership.
- The grants have no immediate impact on customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of transaction: acquisition of stock options and restricted stock units |
| 02/01/2025 | First vesting date for 25% of the stock options and RSUs |
| 02/28/2034 | Expiration date of the stock options |
| 03/05/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.